Today, Congressmen Bruce Westerman (R-AR), Brad Wenstrup, D.P.M. (R-OH), and John Joyce, M.D. (R-PA), leaders of the Republican Healthy Future Task Force Subcommittee on Treatments, announced the GOP's agenda to lower drug costs and supercharge the availability and development of life-saving cures and devices. Rep. Bruce Westerman released the following statement:
"I am greatly looking forward to working with my colleagues to create legislation that will directly address the issues that have long troubled the American health care system," said Rep. Westerman. "If we have learned anything from the COVID-19 pandemic, it's that health care cannot be met with a 'one-size-fits-all' solution from the government. We must empower and work with the private sector to ensure patients are met with cures, not red tape."
The Treatments subcommittee will develop legislation to:
- Lower drug costs for Americans
- Unleash new, innovative medicines, devices, and diagnostics for patients
- Promote American made medicines
Background
The Healthy Future Task Force was created by House Republican Leader Kevin McCarthy to develop solutions to empower patients, lower costs, and expand choices and treatments for a healthier America.
Today, the subcommittee was joined by the leaders of the Healthy Future Task Force, Reps. Vern Buchanan (R-FL) and Brett Guthrie (R-KY), to participate in a roundtable discussion on the innovative treatment solutions with key stakeholders and patient advocates.
Sue Peschin, President and CEO of Alliance for Aging Research, Former Rep. Erik Paulsen, Chair of Institute for Gene Therapies, and Khrystal K. Davis, JD, Founding President of Texas Rare Alliance joined the Congressmen in the roundtable.
Read Reps. Wenstrup's, Joyce's, and Westerman's oped published in The Hill today on the subcommittee's plans here.
Original source can be found here.
